Drug Discovery

Discovery Biology - Assay Development and HTS

InSymbiosis has a wealth of experience in early phase drug discovery. Our expertise in assay development and high-throughput screening (HTS) enables us to take discovery projects from the cloning of the target through HTS into lead optimization.

Drug Target Cloning and Expression

  • Cloning and expression in bacterial, yeast and mammalian systems
  • Custom cell line generation and characterization
  • Protein purification and characterization
  • Large scale protein production
  • Cell culture scale up and membrane production

Assay Development

  • Biochemical:
    • Direct enzyme activity (kinase, phosphatase, protease)
    • Immunoassays (ELISA and ELISA conversions)
    • Receptor binding (GPCRs, RTKs, ion channels)
    • Protein-protein interactions
    • Biacore (SPR) technology (label-free study of biomolecular interactions)
  • Cell based assays:
    • Second messenger (e.g. cAMP) for GPCRs
    • Patch clamp electrophysiology for ion channels
    • Gene reporter
    • Cell proliferation, viability, cytotoxicty
    • Apoptosis
    • Cell motility, invasion
    • FACS methods

High Throughput Screening


Automated Planar Patch Clamp For Ion Channels

  • Pre-validated (e.g. hERG) and custom assays available

Compound Libraries

  • Commercial library, collection of plant extracts, synthetic & commercial compounds, and known drug molecules
  • Design and generation of small molecule libraries and peptides/peptide mimetics

Please see our Drug Discovery brochure for more details or Contact Us.